Market Closed -
Euronext Bruxelles
09:05:18 26/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
60.2
EUR
|
+1.69%
|
|
+2.91%
|
-5.42%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,785
|
3,244
|
4,172
|
3,021
|
3,027
|
2,863
|
-
|
-
|
Enterprise Value (EV)
1 |
3,626
|
4,887
|
6,238
|
5,460
|
3,027
|
5,242
|
5,329
|
5,287
|
P/E ratio
|
17.7
x
|
15.1
x
|
14.2
x
|
8.7
x
|
114
x
|
15.7
x
|
12.9
x
|
11.6
x
|
Yield
|
2.47%
|
4.68%
|
2.96%
|
4.88%
|
5.97%
|
6.48%
|
6.45%
|
6.51%
|
Capitalization / Revenue
|
23.6
x
|
12.5
x
|
18
x
|
11.1
x
|
9.63
x
|
8.51
x
|
8.07
x
|
7.8
x
|
EV / Revenue
|
30.7
x
|
18.8
x
|
26.9
x
|
20
x
|
9.63
x
|
15.6
x
|
15
x
|
14.4
x
|
EV / EBITDA
|
37.1
x
|
23.1
x
|
32.3
x
|
23.8
x
|
11.4
x
|
17.8
x
|
17.5
x
|
16.5
x
|
EV / FCF
|
-175
x
|
-27.2
x
|
-54.5
x
|
-
|
-
|
718
x
|
29.9
x
|
-
|
FCF Yield
|
-0.57%
|
-3.68%
|
-1.83%
|
-
|
-
|
0.14%
|
3.34%
|
-
|
Price to Book
|
1.95
x
|
1.5
x
|
1.5
x
|
0.92
x
|
-
|
0.8
x
|
0.8
x
|
0.79
x
|
Nbr of stocks (in thousands)
|
24,601
|
32,996
|
36,308
|
39,855
|
47,550
|
47,550
|
-
|
-
|
Reference price
2 |
113.2
|
98.30
|
114.9
|
75.80
|
63.65
|
60.20
|
60.20
|
60.20
|
Announcement Date
|
04/09/19
|
24/02/21
|
23/02/22
|
16/02/23
|
21/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
118
|
259.5
|
232.1
|
273.1
|
314.2
|
336.4
|
354.6
|
366.9
|
EBITDA
1 |
97.79
|
211.6
|
193.3
|
229.7
|
265.8
|
294.6
|
303.9
|
320.5
|
EBIT
1 |
97.14
|
211.6
|
193.3
|
229.7
|
265.8
|
276.5
|
295
|
308.2
|
Operating Margin
|
82.32%
|
81.55%
|
83.29%
|
84.09%
|
84.61%
|
82.2%
|
83.18%
|
83.99%
|
Earnings before Tax (EBT)
1 |
-
|
199.8
|
339.6
|
386.4
|
-3.067
|
-22.9
|
270.8
|
247.7
|
Net income
1 |
123.5
|
173.1
|
281.8
|
331.8
|
24.54
|
37.8
|
251.8
|
268.7
|
Net margin
|
104.66%
|
66.69%
|
121.41%
|
121.47%
|
7.81%
|
11.24%
|
71%
|
73.23%
|
EPS
2 |
6.410
|
6.530
|
8.100
|
8.710
|
0.5600
|
3.830
|
4.682
|
5.183
|
Free Cash Flow
1 |
-20.75
|
-179.6
|
-114.4
|
-
|
-
|
7.3
|
178
|
-
|
FCF margin
|
-17.58%
|
-69.21%
|
-49.3%
|
-
|
-
|
2.17%
|
50.19%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
2.48%
|
58.56%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
19.31%
|
70.7%
|
-
|
Dividend per Share
2 |
2.800
|
4.600
|
3.400
|
3.700
|
3.800
|
3.900
|
3.885
|
3.922
|
Announcement Date
|
04/09/19
|
24/02/21
|
23/02/22
|
16/02/23
|
21/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q3
|
2023 S1
|
2023 Q3
|
---|
Net sales
1 |
72
|
108.3
|
-
|
-
|
233.5
|
EBITDA
|
-
|
90.19
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
43.03
|
56.78
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
1.200
|
1.420
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19/02/20
|
11/08/21
|
10/11/21
|
02/08/23
|
31/10/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
841
|
1,643
|
2,066
|
2,439
|
-
|
2,379
|
2,467
|
2,425
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
8.601
x
|
7.765
x
|
10.69
x
|
10.62
x
|
-
|
8.077
x
|
8.115
x
|
7.566
x
|
Free Cash Flow
1 |
-20.8
|
-180
|
-114
|
-
|
-
|
7.3
|
178
|
-
|
ROE (net income / shareholders' equity)
|
10.4%
|
9.62%
|
6.12%
|
5.97%
|
-
|
6.12%
|
6.46%
|
6.53%
|
ROA (Net income/ Total Assets)
|
5.95%
|
-
|
3.28%
|
3.23%
|
-
|
3.7%
|
3.7%
|
-
|
Assets
1 |
2,076
|
-
|
8,584
|
10,286
|
-
|
1,022
|
6,805
|
-
|
Book Value Per Share
2 |
58.10
|
65.60
|
76.60
|
82.40
|
-
|
75.50
|
75.10
|
76.50
|
Cash Flow per Share
2 |
-
|
6.830
|
5.700
|
5.740
|
-
|
4.260
|
-
|
-
|
Capex
1 |
110
|
1,071
|
313
|
-
|
-
|
259
|
186
|
30
|
Capex / Sales
|
92.8%
|
412.76%
|
134.97%
|
-
|
-
|
76.9%
|
52.53%
|
8.18%
|
Announcement Date
|
04/09/19
|
24/02/21
|
23/02/22
|
16/02/23
|
21/02/24
|
-
|
-
|
-
|
Last Close Price
60.2
EUR Average target price
66.13
EUR Spread / Average Target +9.85% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.42% | 3.06B | | +4.62% | 55.76B | | -11.72% | 17.72B | | -5.05% | 13.23B | | +1.40% | 7.68B | | -17.93% | 5.39B | | +8.62% | 3.28B | | -2.31% | 3.23B | | +12.61% | 2.73B | | -13.17% | 2.43B |
Healthcare REITs
|